Mathew Cherian
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
-
- Immune cells in cancer
- T-cell and Retrovirus Studies
Papers in
- Oncology 28
- HER2/EGFR in Cancer Research 13
- Cancer Treatment and Pharmacology 7
- Cancer survivorship and care 4
-
- Advanced Breast Cancer Therapies 13
- Co-authors
- Bhuvaneswari Ramaswamy (28 shared papers)Robert Wesolowski (31 shared papers)Sarmila Majumder (1 shared paper)Priyanka Bhateja (1 shared paper)Mahmoud Kassem (10 shared papers)Sagar Sardesai (16 shared papers)William E. Carson (5 shared papers)Daniel G. Stover (31 shared papers)
- Journals
- Cancer Research (7 papers)Journal of Clinical Oncology (5 papers)Frontiers in Oncology (4 papers)Investigational New Drugs (2 papers)Breast Cancer Research and Treatment (2 papers)
- Partner nations
- United StatesIndiaAustralia
In The Last Decade
Mathew Cherian
54 papers receiving 817 citations
Peers
Comparison fields: 5 of 100
- Oncology 247
- Immunology 146
- Cancer Research 90
- Pulmonary and Respiratory Medicine 155
- Biological Psychiatry 10
Countries citing papers authored by Mathew Cherian
This map shows the geographic impact of Mathew Cherian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathew Cherian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathew Cherian more than expected).
Fields of papers citing papers by Mathew Cherian
This network shows the impact of papers produced by Mathew Cherian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathew Cherian. The network helps show where Mathew Cherian may publish in the future.
Co-authors
The 25 scholars most cited alongside Mathew Cherian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 131 | |
| 2 | 2019 | 106 | |
| 3 | 2020 | 89 | |
| 4 | 2019 | 61 | |
| 5 | 2020 | 35 | |
| 6 | Biochemical and clinical profile after organophosphorus poisoning--a placebo-controlled trial using pralidoxime. | 2005 | 31 |
| 7 | 2023 | 27 | |
| 8 | 2015 | 27 | |
| 9 | 2020 | 26 | |
| 10 | 2020 | 24 | |
| 11 | 2015 | 24 | |
| 12 | 2005 | 22 | |
| 13 | 2018 | 20 | |
| 14 | 2020 | 18 | |
| 15 | 2022 | 15 | |
| 16 | 2017 | 14 | |
| 17 | 2021 | 14 | |
| 18 | 2020 | 13 | |
| 19 | 2022 | 11 | |
| 20 | 2020 | 10 |
About Mathew Cherian
Mathew Cherian is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics and Molecular Biology, having authored 65 papers that have together received 836 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (13 papers), Advanced Breast Cancer Therapies (13 papers), Breast Cancer Treatment Studies (12 papers), Cancer Treatment and Pharmacology (7 papers), Estrogen and related hormone effects (6 papers), T-cell and Retrovirus Studies (4 papers), Cancer survivorship and care (4 papers) and Vector-Borne Animal Diseases (3 papers). The work is most often cited by research in Oncology (247 citations), Immunology (146 citations), Cancer Research (90 citations), Pulmonary and Respiratory Medicine (155 citations) and Biological Psychiatry (10 citations). Mathew Cherian has collaborated with scholars based in United States, India and Australia. Frequent co-authors include Bhuvaneswari Ramaswamy, Robert Wesolowski, Sarmila Majumder, Priyanka Bhateja, Mahmoud Kassem, Sagar Sardesai, William E. Carson, Daniel G. Stover, Brooke Benner and Dionisia Quiroga. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Frontiers in Oncology, Investigational New Drugs and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.